News Johnson & Johnson HIV vaccine trial fails mid-stage study By - August 31, 2021 0 207 Facebook Twitter Pinterest WhatsApp A Johnson & Johnson HIV vaccine candidate failed to reduce the risk of infection in a clinical trial among women in southern Africa.